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Abstract
Objectives: Self-collection of genital specimens for high-risk types of human papillomavirus (hrHPV) detection may
increase cervical cancer screening uptake. We hypothesized that women would prefer self-collection to clinician-collection of
genital specimens. To test this hypothesis, and women’s preference between two different self-collection approaches, a total
of 199 women were enrolled in a cross-sectional study in Mombasa, Kenya.
Materials and methods: Participants provided self-collected specimens using the Evalyn cytobrush (Rovers) stored in a dry
tube and the Viba cytobrush (Rovers) stored in wet Aptima media (Hologic). A clinician also collected cervical specimens for
hrHPV testing and for cytology, and performed visual inspection using acetic acid. A post-examination questionnaire
assessed preferences for the different methods of specimen collection. To test the difference in proportions for each
collection method, we performed an exact binomial probability test, under the null hypothesis that women would
prefer each specimen-collection method equally.
Results: Most women preferred clinician-collection over self-collection (68% versus 32%, p < 0.01). For self-collection,
dry-self collection with the Evalyn brush was preferred over the wet-selection with the Viba brush (53% versus 27%, p
< 0.01). There was no association between preference for self-collection and preference for a particular self-collection
cytobrush.
Conclusion: Further research to understand and address obstacles to self-collection of genital specimens may be
needed to improve the uptake of self-collection for cervical cancer screening, especially in settings with poor access to
trained healthcare providers.
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Plain English summary
Testing for high-risk sub-types of human papillomavirus
(hrHPV) is an effective way of screening for cervical
cancer. Unlike Pap smears which have to be performed
by a clinician, women can self-collect genital samples for
HPV testing. Such samples often produce results that
are as accurate as those obtained from clinician-col-
lected samples.
Between August 2013 and April 2015, we conducted a
study among 199 women at high risk of sexually trans-
mitted infections (STIs) and HIV in Mombasa, Kenya.
Our aim was to find out if the women preferred to col-
lect their own genital samples or have samples collected
by a clinician, and between two self-collection brushes,
which one they would like most. Study participants per-
formed self-collection in a private room, followed by
clinician-collection and a pap smear.
More than two thirds (68%) of the women preferred to
have a clinician collect the genital samples. For
self-collection, majority of women (53%) preferred the
Evalyn brush, which was stored and transported without
any preservative (dry) compared to the Viba brush, which
was stored and transported in a liquid preservative.
Further research is needed to find out reasons why
women in this setting prefer to have genital samples col-
lected by a clinician rather than to collect samples them-
selves, considering that self-collected vaginal samples is
likely to be easier, more comfortable, less embarrassing
and just as accurate as those collected by a clinician. Un-
derstanding such factors may help to scale-up
self-testing, which may increase the number of women
who screen for cervical cancer.
Background
Detection of high-risk human papillomavirus (hrHPV) in
genital specimens is current being used in conjunction
with (co-testing) or as an alternative to Papanicolau (Pap)
smears for primary cervical cancer screening [1–6]. Test-
ing for hrHPV in genital specimens has demonstrated
significantly greater sensitivity as compared to con-
ventional Pap smear for detecting high-grade cervical
intra-epithelial neoplasia (CIN 2+) [2, 6, 7]. Additionally,
women can self-collect cervico-vaginal specimens for
hrHPV testing. These self-collected specimens demon-
strate similar sensitivity and specificity to clinician-
collected specimens for detecting high-grade cervical le-
sions (CIN 2+), and may improve access to screening [8].
Studies conducted in Europe, North and South America
looking at the acceptability of self-collection of genital
specimens for hrHPV testing indicate that self-collected
HPV genital specimens were preferred compared to the
conventional Pap smears for HPV screening. In the latter
one study from South America, age and level of education
were strongly correlated with increased preference for
self-collection [4, 9]. Few studies [10, 11] have explored
the acceptability of self-collection of genital specimens in
Africa, where cultural and religious beliefs concerning
both clinician and self-collection of genital specimens may
be an important consideration. Understanding women’s
preference for self-collection versus clinician-collection of
specimens will help to guide future interventions for cer-
vical cancer screening.
Our study, conducted in a cohort of high-risk women
in Mombasa, Kenya, assessed women’s preference for
self-collection versus clinician-collection of genital speci-
mens for detection of hrHPV for primary cervical cancer
screening. We also explored women’s preference be-
tween two different self-collection devices, the Viba
cytobrush (Rovers®, Netherlands), which required a li-
quid transport media, and the Evalyn cytobrush (Rovers®,
Netherlands), which did not. Based on existing data, we
hypothesized that women would prefer self-collection
over clinician collection [9]. Due to the presumed ease
of collection, we also hypothesized that Evalyn cytobrush
(dry) would be preferred over the Viba cytobrush (in li-
quid media) for self-collection of specimens.
Materials and methods
Study design
We conducted a clinic-based, cross-sectional study from Au-
gust 2013 to April 2015. A total of 200 women participating
in a cohort study of women at high risk of acquiring sexually
transmitted infections (STIs) and HIV in Mombasa, Kenya
were enrolled. Clinical procedures, including self-collection of
hrHPV specimens, were performed at the Ganjoni Health
Centre in Mombasa. Study procedures were integrated into
the ongoing follow-up procedures for the Mombasa Cohort
[12, 13]. Briefly, the Mombasa Cohort is an open cohort study
of female sex workers (FSWs) established in 1993 as a HIV in-
cidence cohort. FSW are recruited from major sex work
venues in Mombasa. Those interested are referred to the re-
search clinic, located in the Ganjoni Municipal Clinic. Women
are invited into this parent cohort if they are 18–45 years old,
reside in Mombasa area, are self-identifying as exchanging sex
for payment in cash or in kind and are able to provide in-
formed consent. Routine cohort visits are scheduled every
month. Every 3 months, the scheduled visit procedures in-
clude collection of genital specimens for Chlamydia tracho-
matis and Neisseria gonorrhea nucleic acid amplification
testing (NAAT). For this ancillary study, we invited women
whose study visits coincided with the NAAT specimen collec-
tion visit. We used convenience sampling to enroll those who
agreed to participate from among those who were eligible.
Study visit procedures
A study nurse briefly introduced the study to eligible
women and invited them to participate. Women who
agreed to participate were referred to the study
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counselor, who provided further information and
responded to questions. Following this discussion with
the counselor, interested participants were required to
provide written informed consent.
Self-collection of genital specimens was conducted in
a private room at the health facility. A study nurse pro-
vided verbal instructions on self-collection procedures,
after which participants performed the procedure on
their own. Pictorial diagrams with detailed instructions
on self-collection were also available in the room. Each
woman performed self-collection using the two different
specimen brushes, the Evalyn cytobrush (Rovers®,
Netherlands), and the Viba cytobrush (Rovers®,
Netherlands). To minimize potential bias from the order
of specimen collection, women had study numbers
assigned to them based on their enrollment into the
study, and those with odd study numbers self-collected
using the Evalyn brush first, while those with even study
numbers self-collected using the Viba cytobrush first.
The physical characteristics and specimen handling
slightly differ between these two devices (Fig. 1). For
both cytobrushes, self-collected specimens were ob-
tained by inserting the collection brush and following
the manufacturer’s instructions to sample cells from the
cervico-vaginal wall.
The Evalyn cytobrush is pink in color, and consists of
a plunger containing white bristles made of polyethylene
at the tip, a transparent casing, and a transparent cap.
For self-collection, women were instructed to squat, pull
the plunger down into the clear casing to protect the
bristles, and gently insert the brush into the vagina.
Next, they pushed the plunger back up to expose the
bristles, and rotated the brush through five complete
turns in the same direction for specimen collection.
Each complete rotation was accompanied by an audible
click on the device. Self-collection using the Evalyn
brush was “dry,” in that there was no need to place the
specimens in a preservative for transportation to the
laboratory.
The Viba brush consists of a blue handle and an easily
removable white tip. The tip contains bristles made of
similar material as the Evalyn brush. The Viba brush was
provided with a cryovial containing 1 ml of Aptima
media (Hologic®, USA). After self-collection, participants
broke off the brush head at the tip of the cytobrush and
deposited it into the cryovial containing Aptima media.
After self-collection, a study clinician performed a
speculum-assisted pelvic examination, which included
collection of cervical specimen for hrHPV testing.
Clinician-collection of specimens was performed using a
cervical specimen collection brush (Hologic®, USA). Un-
like self-collected specimens, clinician specimens were
collected from the endocervix. Similar to the Viba brush,
clinician-collected specimens were stored in Aptima
media (Hologic®, USA). After hrHPV specimen collec-
tion, the clinician performed visual inspection under
acetic acid and a conventional Pap smear. All clinicians
in this study had extensive training and experience in
Evalyn cytobrush (Rovers®, 
Netherlands) 
The Viba cytobrush (Rovers®, 
Netherlands) with cryovial containing 
Aptima media (Hologic)
Fig. 1 The Evalyn cytobrush (left side) and the Viba cytobrush with cryovial containing Aptima media (right side)
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genital examination and specimen collection as part of
the procedures in the Mombasa Cohort.
Post-examination questionnaire to assess women’s
preference
Following the clinical examinations, women participated
in a structured interview using a standardized question-
naire to assess their preferences for different methods of
specimen collection. For the question on self-collection
versus clinician-collection, women were asked, “If you
were to be tested for hrHPV infection again, how would
you like the specimen to be collected?” They gave their
answers as either self-collection or clinician-collection.
To assess women’s preferences between the Evalyn
and Viba cytobrushes, they were asked, “Which of the
two brushes you collected yourself did you like best?”
They were then asked to select one of three possible re-
sponses; “I liked the blue brush (Viba brush),” “I liked
the pink brush (Evalyn brush),” and “I liked them both
equally”. To explore women’s perceptions of specific
characteristics of the two brushes, they were asked four
questions. Their responses to these questions were
graded on a 5-point Likert scale, with a range of one for
“strongly agree”, two for “agree somewhat”; three for
“neutral”; four for “disagrees somewhat”; and five for
“strongly disagree.” The four questions were: “Was the
brush comfortable to insert?” “Were you concerned
about hurting yourself with the brush?”, “Were you con-
cerned about using the brush properly?”, and, “Were the
instructions for self-collection using the brush easy to
understand?”
Statistical analysis
The primary aim of the study was to test the hypothesis
that women would prefer self-collection to
clinician-collection of genital specimens. To test the dif-
ference in proportions for each collection method, we
performed an exact binomial probability test, under the
null hypothesis that women would prefer each
specimen-collection method equally (i.e., p = 0.50 for
selecting self-collection or clinician-collection). To de-
termine which self-collection cytobrush was most pre-
ferred, we compared the proportion of women who
preferred the Evalyn brush to those who preferred the
Viba brush and to those who preferred them both
equally. To determine the statistical significance of this
difference, we performed a one-sample t-test, with re-
sponses distributed between 0 for the Viba brush, 1 for
no preference, and 2 for the Evalyn brush, testing the
null hypothesis of no difference in preference (i.e., mean
preference = 1.0).
Log-binomial regression analyses were performed to
explore the predictors of preference for clinician collec-
tion versus self-collection. The variables tested were
identified a priori through a review of the literature. We
included factors associated with self-testing for other
conditions (HIV) and those associated with screening
for cervical cancer. These included women’s age at first
sexual intercourse [14], current age [15], level of
education [16, 17], marital status [16], parity [15], and
religion [18].
To explore predictors of preference for the dry
self-collection brush, wet self-collection brush, and pref-
erence for both equally, we performed a multinomial lo-
gistic regression analysis, with no preference as the
referent category. The predictors included in the models
were similar to those included in our analysis of predic-
tors of preference for self-collection versus clinician-col-
lection. Relative risk ratios greater than 1 in this analysis
indicated a higher probability of preferring the brush
specified, relative to having no preference. Conversely,
relative risk ratios less than 1 indicated a lower probabil-
ity of preferring the brush specified, relative to having
no preference. We performed chi-squared tests to ex-
plore whether there was an association between prefer-
ence for self-collection and preference for a particular
collection device. Finally, to better understand women’s
preferences for specific collection devices, we explored
their perceptions about characteristics of the two
brushes. Median and interquartile ranges were used to
summarize the responses to each question that was
graded on a Likert scale. Wilcoxon signed-ranks tests
were performed to analyze differences in paired re-
sponses to each of these questions for the Evalyn brush
compared to the Viba brush. All analyses were per-
formed using STATA version 13.
Results
Between August 2013 and April 2014, a total of 200
women were enrolled into the cervical cancer screening
study. Of these, 199 (99%) participated in the
post-examination interview and were included in ana-
lyses. Mean age of study participants was 37.6 years,
range (30–44) and approximately half were HIV-positive
(Table 1).
Of 199 women, 63 (32%) reported preference for
self-collection compared to 136 (68%) who reported
preference for clinician-collection (exact binomial prob-
ability test, p < 0.001). Baseline demographic and clinical
characteristics were broadly similar between women
who preferred clinician-collection and those who pre-
ferred self-collection. Univariate log-binomial regression
analyses of predictors of preference for self-collection
found that older age at sexual debut was significantly as-
sociated higher with preference for clinician-collection
versus self-collection (odds ratio [OR] 1.10, 95% confi-
dence interval [CI] 1.02–1.10, p = 0.02) (Table 2).
Manguro et al. Reproductive Health          (2018) 15:206 Page 4 of 8
For self-collection, the Evalyn brush was generally pre-
ferred (n = 105; 53%), compared to the Viba brush (n =
50; 25%), and equal preference for both brushes (n = 44;
22%) (One-sample t test p < 0.001). We found no associ-
ation between preference for specimen collection
method self-versus clinician) and preference for
self-collection cytobrush (Chi-square test, p = 0.69). In
univariate multinomial logistic regression analyses, age,
parity, comfort when using the brush and concerns of
getting hurt while using the brush were significantly as-
sociated with preference for a particular self-collection
method (Table 3). In multivariable analyses, increased
comfort with the Evalyn brush was associated with lower
probability of selecting the Viba brush (OR 0.48, 95% CI
0.32–0.71), and increased concerns about hurting them-
selves with the Viba brush were associated with an in-
creased probability of selecting the Evalyn brush (OR
1.33, 95% CI 1.05–1.71).
Table 4 presents responses to questions comparing
women’s experience with the Evalyn and Viba cyto-
brushes, together with p-values from the test for differ-
ences in paired responses to each of these questions.
Participants strongly agreed that instructions for both
Table 1 Baseline characteristics of 199 female sex workers from
Mombasa, Kenya
Characteristic Mean (SD) or Number
(percent)
Age (years) 37.6 (9.5)
Age at first sex (years) 16.9 (2.3)
> 8 years of education (At least some high-
school)
91 (46%)
Ever pregnant 183 (92%)





Using modern contraception other than condoms alone
No contraceptive method 63 (32%)
Hormonal contraceptive use 53 (27%)
Non-hormonal contraceptive use 83 (41%)
HIVseropositive 101 (51%)
aIncludes traditional African religions and no religious affiliation
Table 2 Univariate log-binomial regression analyses exploring predictors of women’s preference for clinician-collection versus self-























Age (years) 38.2 (9.7) 36.4 (9.1) 0.99 (0.97–1.0) 0.25
Age at first sex (years) 16.6 (2.2) 17.4 (2.4) 1.10 (1.02–1.19) 0.02
Parity
Nulliparous 44% 9 (7%) 7 (11%) Reference
Ever pregnant 31% 127 (93%) 56 (89%) 0.71 (0.39–1.28) 0.26
Education
8 years and less 27% 79 (58%) 29 (46%) Reference
v > 8 years 37% 57 (42%) 34 (54%) 1.39 (0.92–2.10) 0.11
Marital status
Never married 30% 55 (40%) 24 (38%) Reference
Ever married 33% 81 (60%) 39 (62%) 1.07 (0.70–1.63) 0.75
HIV status
HIV-negative 35% 64 (47%) 35 (56%) Reference
HIV-positive 28% 72 (53%) 28 (44%) 0.79 (0.52–1.20) 0.27
Religion
Christian 122 (90%) 54 (86%) Reference
Muslim 18 (9) 8 (13%) 1.45 (0.83–2.54) 0.20
Othera 5 (3) 1 (2%) 0.65 (0.11–3.82) 0.64
aTraditional African religions and no religious affiliation
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self-collection brushes were easy to understand. In terms
of analyses comparing women’s experience with the Eva-
lyn and the Viba cytobrushes, for the questions, “Were
the instructions for self-collection using the brush easy
to understand?” and, “Were you concerned about using
the cytobrush properly?” women rated both self-collec-
tion cytobrushes equally and favorably. For the question
“Were you concerned about hurting yourself with the
brush?” responses were more favorable for the Evalyn
brush as compared to the Viba brush. For the question
“Was the brush comfortable to insert?” a significantly
greater proportion of women reported comfort with the
Evalyn brush compared to the Viba brush.
Discussion
In this study of 199 high-risk Kenyan women participat-
ing in an HIV incidence cohort, significantly more par-
ticipants preferred to have specimens for hrHPV testing
collected by a clinician rather than self-collected sam-
pling. When directly comparing the two self-collection
Table 3 Multinomial regression analysis exploring predictors of women’s preference for the Viba or the Evalyn cytobrush
Variable Prefers Viba cytobrush Prefers Evalyn cytobrush
Relative risk ratio (95% CI) p-value Relative risk ratio (95% CI) p-value
Age (years) 0.92 (0.88–0.97) 0.001 0.94 (0.91–0.98) 0.004
Age at first sex (years) 1.07 (0.89–1.28) 0.47 1.05 (0.90–1.23) 0.55
Parity
Nulliparous Reference Reference
Ever pregnant 0.68 (0.52–0.90) 0.008 0.82 (0.65–1.02) 0.07
Education
No high school education Reference Reference
At least high school-level 1.22 (0.54–2.78) 0.63 1.42 (0.70–2.88) 0.34
Marital status
Never married Reference Reference
Ever married 0.81 (0.35–1.85) 0.62 0.95 (0.46–1.95) 0.88
HIV status
HIV-negative Reference Reference
HIV-positive 1.16 (0.51–2.63) 0.72 0.62 (0.31–1.26) 0.19
Religion
Christian Reference Reference
Muslim 0.35 (0.07–1.93) 0.23 0.92 (0.30–2.83) 0.89
Othera 2.66 (0.27–26.62) 0.41 0.42 (0.03–6.87) 0.54
Evalyn brush more comfortable to insertb 0.64 (0.46–0.89) 0.009 1.38 (0.92–2.06) 0.12
Viba brush more comfortable to insert b 1.48 (1.01–2.16) 0.04 0.69 (0.55–0.87) 0.002
Concerned about hurting themselves with Evalyn brush b 1.25 (0.98–1.58) 0.07 0.89 (0.72–1.09) 0.25
Concerned about hurting themselves with Viba brush b 0.93 (0.74–1.18) 0.56 1.38 (1.12–1.69) 0.002
aTraditional African religions and no religious affiliation
bFor this analysis, the rating scale for these questions was reverse coded (5 strongly agree, 4 agree somewhat, 3 neutral, 2 disagree somewhat, 1 strongly
disagree) so that increasing ratings indicated agreement with each item and higher relative risk ratios indicated a higher probability of preferring the
brush specified
Table 4 Median scores and interquartile range for responses to questions on experience when using the cytobrushes and p-values
from the Wilcoxon signed ranks test for differences in each paired response
Question Evalyn Viba p value
Median (IQR) Median (IQR)
Were the instructions on using brushes easy to understand? 1 (1–1) 1 (1–1) 0.08
Were you concerned about using the brush properly? 2 (1–4) 2 (1–4) 0.15
Were you concerned about hurting yourself? 4 (1–5) 2 (1–5) 0.0004
Was the brush comfortable to insert? 1 (1–1) 1 (1–4) < 0.001
(1 strongly agree, 2 agree somewhat, 3 neutral, 4 disagree somewhat, 5 strongly disagree)
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devices, most women preferred the self-collection Evalyn
brush stored “dry” to the Viba brush stored in liquid
media. Women strongly agreed that both self-collection
brushes were comfortable during use, and the instruc-
tions easy to follow. For both self-collection approaches,
most women somewhat agreed that they were concerned
about performing self-collection properly.
Women in several studies from the US and Europe
reported a preference for self-collection compared to
clinician-collection for hrHPV specimen collection [4, 19,
20]. A meta-analysis including eight studies from Europe
and two from North America also reported that, among
women who did not routinely screen for cervical cancer,
compliance was better when using self-collected genital
specimens as initial screening as opposed to pap smears
[4]. In contrast, one study from Cameroon reported that
while women found self-collection more comfortable and
less embarrassing, a greater proportion of women still pre-
ferred to have genital specimens collected by a clinician
(62% vs. 29%, p < 0.001) [21]. In this African population,
women reported greater concerns about the reliability of
results from self-collected specimens as compared to
clinician-collected specimens (59% vs. 1%). Our results
suggest that Kenyan women may have similar concerns
about the reliability of self-collected specimens. When
asked, “Were you concerned about using the cytobrushes
properly?” most of the women’s response was “agreed
somewhat” (Table 4). This is in contrast to their responses
on questions pertaining to the specific characteristics of
the brushes, which were consistently very favorable. Most
women, for example, felt that the self-collection brushes
were comfortable to use, and instructions for self-collec-
tion easy to follow.
While the overall rating for both cytobrushes was posi-
tive, the Evalyn cytobrush was generally more preferred.
Importantly, the majority of women in this study who
reported greater preference for the Evalyn brush also
found the cytobrush more comfortable to insert, and re-
ported greater fears of hurting themselves with the Viba
cytobrush. These two may be explained by the difference
in physical characteristics of the Evalyn cytobrush. The
cytobrush has a plunger, which allowed the women to
pull down the bristles into the transparent casing at the
point of insertion. The Evalyn brush also has wings
which marks the furthest point the cytobrush can be
inserted into the vagina. It is possible that these two
characteristics may contribute to the greater comfort
and less fears of hurting themselves when using the Eva-
lyn brush. Additionally, women did not have to detach
the tip of the Evalyn brush and insert into the liquid
transport media and merely replaced the plastic cap after
self-collection as the cytobrush was stored and trans-
ported dry. The finding that women reported a prefer-
ence for one cytobrush over the other for self-collection
is important for the potential scale-up of self-collection
programs in this region. However, it is important to note
that it is unknown whether women’s preference for the
Evalyn brush would have a meaningful impact on
self-collection program coverage if only an alternative
like the Viba brush were offered.
It is interesting to note that while findings from our
study and the Cameroonian study [21] agree, the study
populations are distinctly different. Our study was con-
ducted in female sexual workers at a notably high risk of
infection with HIV and STIs, who regularly attended
clinic and had frequent pelvic examinations. In contrast,
the study from Cameroon was conducted in general
population with limited exposure to pelvic examinations.
The parallel findings from these two distinct populations
of African women may point towards a general prefer-
ence for clinician-collected genital specimens among
women from this region, although more research is war-
ranted to confirm these findings.
Our study has several strengths. Few other studies in
sub-Saharan Africa have evaluated women’s preference be-
tween different methods of genital specimen-collection
for hrHPV testing. East Africa contributes a significant
burden of invasive cervical cancer globally, and reports
one of the lowest proportion of reproductive-aged women
having been screened for cervical cancer [22]. In addition,
our study was conducted in a cohort of women at a par-
ticularly high risk for hrHPV and high-grade cervical le-
sions. Interventions aimed at improving hrHPV testing in
this population are, therefore, likely to be of great benefit
in terms of reducing preventable cervical cancer and asso-
ciated mortality.
One important limitation of our study was that
self-collection of genital specimens was conducted in a
clinic setting. Women had to present to a health facility
to conduct the self-test. Part of the challenge of cervical
cancer screening in East Africa is poor access to health
facilities. It is plausible that women would appreciate
self-collection more if they were offered the additional
convenience of self-collection at home or in another
non-clinical setting. Another limitation was that this
study was conducted in a group of women who were
part of an ongoing cohort study in which pelvic exami-
nations with collection of genital specimens for STI
screening is routine. It is possible that the women in this
population have grown more comfortable with clinical
examinations compared to women in the general
population.
Conclusion
In conclusion, our findings suggest that high-risk women
in sub-Saharan Africa may prefer clinician-collection, ra-
ther than self-collection, for hrHPV testing. Areas with
inadequate healthcare infrastructure, especially those
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with few trained clinicians to conduct pelvic examina-
tions, would benefit greatly from scale-up of
self-collection for cervical cancer screening. In this re-
gard, education about the validity, safety and ease of
self-collected specimens for hrHPV detection will be im-
portant to enhance uptake of self-collection of genital
specimens for cervical cancer screening.
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